DrugDashboards

Market view

hydrocodone bitartrate and homatropine methylbromide · Syrup

1 marketed package NDCs · 1 active manufacturer

Most dispensed: 5 mg/5mL; 1.5 mg/5mL · Solution · #473 mL/bottle · 5 mg; 1.5 mg · Tablet · #100 tablets/bottle · 5 mg; 1.5 mg · Tablet · #30 tablets/bottle · 5 mg; 1.5 mg · Tablet · #100 tablets/bottle, plastic

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for hydrocodone bitartrate and homatropine methylbromide, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Opioid Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Hydrocodone bitartrate and homatropine methylbromide in shortage right now?
No. FDA does not currently list Hydrocodone bitartrate and homatropine methylbromide in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Hydrocodone bitartrate and homatropine methylbromide?
6 companies have marketed Hydrocodone bitartrate and homatropine methylbromide in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Hydrocodone bitartrate and homatropine methylbromide cost?
The typical pharmacy pays about $0.9434 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.